Friday, April 24
AMD surges 14% on Intel's AI demand signal
Intel's strong results triggered a read-across rally in AMD, while Tesla's capex guidance and Apple's CEO transition introduced fresh uncertainty in two mega-cap positions.
Top Stories
AMD jumps 14% on Intel's AI-driven CPU demand signal
Intel's strong Q1 results signaled that agentic AI applications are accelerating data center CPU procurement cycles, and analysts immediately applied that logic to AMD. The move is meaningful but indirect - AMD has not yet reported its own results, so this is a sentiment and read-across trade rather than confirmed AMD-specific demand. Watch AMD's upcoming earnings report to find out whether Friday's repricing reflects durable structural demand or a halo effect that gets partially given back.
Tesla raised 2026 capex guidance to $25 billion for AI and Robotaxi development
Tesla beat Q1 earnings expectations but raised 2026 capital expenditure guidance to $25 billion for AI and Robotaxi development, a known-unknown that pressures near-term free cash flow even as profitability improves. Apple separately announced that CEO Tim Cook will step down in September, with hardware chief John Ternus named as successor. This transition raises genuine questions about strategic direction at a company whose growth engine is now services and ecosystem, not hardware cycles. Neither development is a crisis, but both introduce a new layer of uncertainty that investors will be pricing for months.
Eli Lilly's oral GLP-1 drug trails Novo Nordisk in early prescription data
Early script data for Eli Lilly's oral Foundayo showed it underperforming Novo Nordisk's oral Wegovy, a competitive signal that matters because the oral market launch was a key catalyst the stock had already priced in. Shares fell 3.64% on the news. Procter and Gamble delivered a cleaner quarter on the surface, beating Q3 EPS estimates at $1.59 versus the $1.56 consensus on 7% volume-led organic sales growth, but warned of a $150 million annual profit headwind from Middle East conflict-driven input cost inflation and guided full-year EPS toward the low end of its range. Both companies illustrate the same theme this earnings season: strong franchises are absorbing real external pressure that qualifies otherwise solid results.
Also Today
- Canada approved Enbridge's $4 billion BC gas pipeline expansion
- Union rally cut Samsung chip output up to 58% overnight
- Monte dei Paschi appointed Lovaglio as CEO after governance turmoil
Takeaway
AMD's 14% rally is a read-across trade on Intel's AI demand signal, not confirmed AMD-specific strength. The real risk is in healthcare and consumer, where Eli Lilly and Procter and Gamble both showed that external pressures are eroding margin quality even when top-line beats land. Tesla and Apple's guidance and leadership changes will dominate the next two weeks of earnings volatility.
